Helen W. Boucher, MD FACP FIDSA, Chief, Division of Geographic Medicine and Infectious Diseases; Director, Heart Transplant and Ventricular Assist Device Infectious Diseases Program; Tufts Medical Center; Director, Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR)

​

Jonathan Daniels, Senior Manager, Policy & Advocacy, Cystic Fibrosis Foundation

​

Quardricos Driskell, Vice President of Public Policy & Government Affairs, Autoimmune Association

​

Greg Frank, Director, Global Public Policy, Merck

​

Phyllis E. Greenberger, MSW, Senior Vice President of Science & Health Policy, HealthyWomen 

​

Nicholas Harrison, MPH, MA, Senior Policy Analyst, Duke-Margolis 

​

Amanda Jezek, Senior Vice President, Public Policy and Government Relations, Infectious Diseases Society of America 

​

Kevin Outterson, Founder and Executive Director, CARB-X; Professor, Boston University School of Law

​

John Rex, Chief Medical Officer, F2G Limited; Founder, AMR.Solutions

​

Mark Williams, Associate Director, FasterCures, a Center of the Milken Institute 

​

Monika Schneider, PhD, Director, Global Antimicrobial Resistance Policy, Shionogi

​

​​Kenneth E. Thorpe, PhD, Chairman, Partnership to Fight Chronic Disease, Robert W. Woodruff Professor and Chair, Department of Health Policy & Management, Rollins School of Public Health, Emory University
 

Jocelyn Ulrich, MPH, Deputy Vice President, Policy, Research and Membership, PhRMA